Angiotensin II

Intensive Care Med. 2024 Feb;50(2):279-282. doi: 10.1007/s00134-023-07290-7. Epub 2024 Jan 8.

Rinaldo Bellomo^{1

2

3

4

5}, Alexander Zarbock⁶, Giovanni Landoni^{7

8}

¹ Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Rinaldo.bellomo@austin.org.au.
² Department of Critical Care, University of Melbourne, Melbourne, Australia. Rinaldo.bellomo@austin.org.au.
³ Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia. Rinaldo.bellomo@austin.org.au.
⁴ Department of Intensive Care, Austin Hospital, Heidelberg, Melbourne, VIC, 3084, Australia. Rinaldo.bellomo@austin.org.au.
⁵ Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia. Rinaldo.bellomo@austin.org.au.
⁶ Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
⁷ Vita-Salute San Raffaele University, Milan, Italy.
⁸ IRCCS San Raffaele Scientific Institute, Milan, Italy.

No abstract available

Publication types